| 000 | 01759 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250515180813.0 | ||
| 264 | 0 | _c20100224 | |
| 008 | 201002s 0 0 eng d | ||
| 022 | _a1569-8041 | ||
| 024 | 7 |
_a10.1093/annonc/mdp258 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSperr, W R | |
| 245 | 0 | 0 |
_aComorbidity as prognostic variable in MDS: comparative evaluation of the HCT-CI and CCI in a core dataset of 419 patients of the Austrian MDS Study Group. _h[electronic resource] |
| 260 |
_bAnnals of oncology : official journal of the European Society for Medical Oncology _cJan 2010 |
||
| 300 |
_a114-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 | _aAustria |
| 650 | 0 | 4 | _aComorbidity |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aKaplan-Meier Estimate |
| 650 | 0 | 4 |
_aLeukemia, Myeloid, Acute _xepidemiology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMyelodysplastic Syndromes _xepidemiology |
| 650 | 0 | 4 |
_aPrecancerous Conditions _xepidemiology |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aWimazal, F | |
| 700 | 1 | _aKundi, M | |
| 700 | 1 | _aBaumgartner, C | |
| 700 | 1 | _aNösslinger, T | |
| 700 | 1 | _aMakrai, A | |
| 700 | 1 | _aStauder, R | |
| 700 | 1 | _aKrieger, O | |
| 700 | 1 | _aPfeilstöcker, M | |
| 700 | 1 | _aValent, P | |
| 773 | 0 |
_tAnnals of oncology : official journal of the European Society for Medical Oncology _gvol. 21 _gno. 1 _gp. 114-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/annonc/mdp258 _zAvailable from publisher's website |
| 999 |
_c19019539 _d19019539 |
||